AB.PA
AB Science SA
Price:  
1.40 
EUR
Volume:  
529,329.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-170.2%
Upside

As of 2025-06-30, the EV/EBITDA ratio of AB Science SA (AB.PA) is -15.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 93.91 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -5.98 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.7x - 6.5x 6.2x
Forward P/E multiples 9.5x - 10.7x 9.8x
Fair Price (1.14) - (0.83) (0.99)
Upside -180.9% - -159.1% -170.2%
1.40 EUR
Stock Price
(0.99) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-27 -15.71
2025-06-26 -14.30
2025-06-25 -14.30
2025-06-24 -15.04
2025-06-23 -15.14
2025-06-20 -13.19
2025-06-19 -13.09
2025-06-18 -13.31
2025-06-17 -13.27
2025-06-16 -13.29
2025-06-13 -13.39
2025-06-12 -13.51
2025-06-11 -13.55
2025-06-10 -13.51
2025-06-09 -13.49
2025-06-06 -13.29
2025-06-05 -12.91
2025-06-04 -13.17
2025-06-03 -13.15
2025-06-02 -13.25
2025-05-30 -13.43
2025-05-29 -13.81
2025-05-28 -14.04
2025-05-27 -13.98
2025-05-26 -14.30
2025-05-23 -14.06
2025-05-22 -14.48
2025-05-21 -15.02
2025-05-20 -15.71
2025-05-19 -16.61
2025-05-16 -16.31
2025-05-15 -16.94
2025-05-14 -16.21
2025-05-13 -16.43
2025-05-12 -16.29
2025-05-09 -16.33
2025-05-08 -16.05
2025-05-07 -16.37
2025-05-06 -16.43
2025-05-05 -16.23
2025-05-02 -16.25
2025-04-30 -15.97
2025-04-29 -16.17
2025-04-28 -16.19
2025-04-25 -16.15
2025-04-24 -16.41
2025-04-23 -15.93
2025-04-22 -15.97
2025-04-17 -16.07
2025-04-16 -15.67